Chemometric Optimization of the Methodology for Determination of Molybdenum in Soils and Plants by Square Wave Adsorptive Stripping Voltammetry
AUTOR(ES)
Carvalho, José Ricardo de; Reis, Efraim Lázaro; Reis, César; Damasceno, Odilaine I. C.; Neves, Antônio Augusto; Matias, Alexsandro Antônio
FONTE
J. Braz. Chem. Soc.
DATA DE PUBLICAÇÃO
2020-04
RESUMO
The method is based on the adsorptive accumulation of complex molybdenum(VI) with 8-hydroxyquinoline, using voltammetric square wave cathodic stripping voltammetry. The composition and concentration of the supporting electrolyte, frequency (Hz), amplitude (mV) and deposition time (s), were optimized by factorial design in relation to current reduction of molybdenum(VI). The optimum methodology provided the following values for the process variables: scan increase (0.5 mV), pulse amplitude (127 mV), frequency (96 Hz), adsorption time (80 s) and drop size (0.60 mm2), the concentration of KNO3 (2.0 mol L-1), acetate buffer (0.5 mol L-1) and 8-hydroxyquinoline (0.01 mol L-1). The results obtained after optimization showed a linear response in the range from 1.0 to 6.0 mg L-1 and limits of detection and quantification, respectively equal to 0.02 and 0.08 mg L-1. The molybdenum contained in the samples were determined using the optimized methodology, with values consistent with the values determined by atomic emission spectrometry with inductively coupled plasma (ICP-AES).
Documentos Relacionados
- Otimização da metodologia de determinação de molibdênio em solos e plantas por voltametria de onda quadrada com redissolução catódica adsortiva
- Optimization of experimental parameters in the determination of zinc in sea water by adsorptive stripping voltammetry
- Experimental design employed to square wave voltammetry response optimization for the glyphosate determination
- Determination of triazines in hemodialysis saline solutions by adsorptive stripping voltammetry after extraction in acetonitrile
- Adsorptive stripping voltammetry determination of the hormone therapy Raloxifene HCl in formulation and human serum